APA (7th ed.) Citation

Hidetaka Wakabayashi, Hidenori Arai, & Akio Inui. (2021). The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: Facts and numbers. Wiley.

Chicago Style (17th ed.) Citation

Hidetaka Wakabayashi, Hidenori Arai, and Akio Inui. The Regulatory Approval of Anamorelin for Treatment of Cachexia in Patients with Non‐small Cell Lung Cancer, Gastric Cancer, Pancreatic Cancer, and Colorectal Cancer in Japan: Facts and Numbers. Wiley, 2021.

MLA (9th ed.) Citation

Hidetaka Wakabayashi, et al. The Regulatory Approval of Anamorelin for Treatment of Cachexia in Patients with Non‐small Cell Lung Cancer, Gastric Cancer, Pancreatic Cancer, and Colorectal Cancer in Japan: Facts and Numbers. Wiley, 2021.